Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) were up 10.7% on Wednesday . The stock traded as high as GBX 1.69 and last traded at GBX 1.55. Approximately 861,674 shares were traded during mid-day trading, an increase of 79% from the average daily volume of 481,347 shares. The stock had previously closed at GBX 1.40.
Cizzle Biotechnology Trading Up 15.7%
The business’s fifty day moving average price is GBX 1.53 and its 200 day moving average price is GBX 1.53. The firm has a market capitalization of £6.42 million, a price-to-earnings ratio of -5.06 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Read More
- Five stocks we like better than Cizzle Biotechnology
- [No Brainer Gold Play]: “Show me a better investment.”
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
